Previously approved for IV infusion.
As people with type 2 diabetes age, the risks of insulin use can outweigh its benefits, creating the need for increased provider and patient education.
FDA approved the first and only ready-to-use insulin for IV infusion in hospitals and acute care settings.
While pharmacy benefit managers were grilled about insulin prices at Congressional hearings last week, some PBMs, insurers and pharma makers are already lowering insulin costs.
Eli Lilly creates generic Humalog priced 50% lower
The new device will increase real-time personalization and predictive diagnostics for patients.
Insulin glargine should not be used past 28 days after the vial is first used, but 80% of patients do.
The immune system could play a beneficial role in regulating insulin, according to a study from Switzerland.
Patients will soon have one less option when selecting insulin.
People with diabetes may have PIR, where they resist starting on insulin therapy, but pharmacists can use these strategies to help them.